Medexus Pharmaceuticals Inc T.MDP

MDP is undervalued and that puzzles me

[GoldenArm]

Did some more research and looked closely at the numbers. I'm puzzled why this is a $7 to $8 stock it should be at the least $12. Way undervalued. Revenue growth was huge 31.5M last quarter which would mean $12/shr value.

I'm adding more because the real story isn't the Nasdaq listing, it is the sales growth for next quarter and so on. If next quarter numbers come out and they are as good as last quarter or better then the stock should be $15/shr. In my opion this stock is a strong buy. GLTA

[Finallytherock]

MDP is very undervalued. I think once they list on the Nasdaq and US institutions get involved, things will get better. The stock price should be $15 now imo based on their growth. The company should do a better job at PR to get investors in this one. Right now they are on track to do about $120+ million in revenue. In August, if they get approval for Treosulfan (sp?), that could add another $150

[GoldenArm]

I doubled my holdings yesterday on the pull back. I'm convinced like you that this will be duble in less than a year and $40 to $60 in a few years. This is a long time hold for me. Management is doing a great job and yes once on the Nas they should think about PR but that cost money and they need those fund to acquire rights to more product. Treosulfan will bump earning but I think it could go